The store will not work correctly when cookies are disabled.
6-Methyl-N-(3-pyridin-2-yl-isoquinolin-1-yl)-pyridine-2-carboxamidine
ID: ALA147918
PubChem CID: 44363600
Max Phase: Preclinical
Molecular Formula: C21H17N5
Molecular Weight: 339.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cccc(C(=N)Nc2nc(-c3ccccn3)cc3ccccc23)n1
Standard InChI: InChI=1S/C21H17N5/c1-14-7-6-11-18(24-14)20(22)26-21-16-9-3-2-8-15(16)13-19(25-21)17-10-4-5-12-23-17/h2-13H,1H3,(H2,22,25,26)
Standard InChI Key: PDLRZUJASSAVIH-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
5.7042 -6.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7042 -6.8792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4167 -5.6417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4167 -7.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4167 -4.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1292 -8.5292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4167 -8.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9917 -5.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7042 -4.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9917 -4.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1292 -4.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8417 -4.8125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1292 -6.8792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1375 -9.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7042 -8.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7042 -9.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2792 -4.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2792 -6.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5542 -4.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1250 -3.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4167 -9.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8542 -9.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5667 -4.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5542 -3.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5667 -5.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8292 -3.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 2 1 0
5 3 1 0
6 7 2 0
7 4 1 0
8 1 1 0
9 10 1 0
10 8 2 0
11 5 1 0
12 11 2 0
13 4 2 0
14 6 1 0
15 7 1 0
16 15 2 0
17 10 1 0
18 8 1 0
19 12 1 0
20 11 1 0
21 16 1 0
22 14 1 0
23 25 1 0
24 26 1 0
25 18 2 0
26 20 2 0
9 5 2 0
23 17 2 0
24 19 2 0
14 21 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 339.40 | Molecular Weight (Monoisotopic): 339.1484 | AlogP: 4.44 | #Rotatable Bonds: 3 |
Polar Surface Area: 74.55 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.65 | CX LogP: 3.94 | CX LogD: 3.94 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.43 | Np Likeness Score: -0.86 |
References
1. de Zwart MA, van der Goot H, Timmerman H.. (1989) Synthesis and copper-dependent antimycoplasmal activity of 1-amino-3-(2-pyridyl)isoquinoline derivatives. 2. Amidines., 32 (2): [PMID:2913309] [10.1021/jm00122a033] |